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Abstract
Background: The extent to which routinely collected HIV data from Zambia has been used in peer-reviewed
published articles remains unexplored. This paper is an analysis of peer-reviewed articles that utilised routinely
collected HIV data from Zambia within six programme areas from 2004 to 2014.
Methods: Articles on HIV, published in English, listed in the Directory of open access journals, African Journals Online,
Google scholar, and PubMed were reviewed. Only articles from peer-reviewed journals, that utilised routinely collected
data and included quantitative data analysis methods were included. Multi-country studies involving Zambia and
another country, where the specific results for Zambia were not reported, as well as clinical trials and intervention
studies that did not take place under routine care conditions were excluded, although community trials which referred
patients to the routine clinics were included. Independent extraction was conducted using a predesigned data
collection form. Pooled analysis was not possible due to diversity in topics reviewed.
Results: A total of 69 articles were extracted for review. Of these, 7 were excluded. From the 62 articles reviewed, 39
focused on HIV treatment and retention in care, 15 addressed prevention of mother-to-child transmission, 4 assessed
social behavioural change, and 4 reported on voluntary counselling and testing. In our search, no articles were found
on condom programming or voluntary male medical circumcision. The most common outcome measures reported
were CD4+ count, clinical failure or mortality. The population analysed was children in 13 articles, women in 16 articles,
and both adult men and women in 33 articles.
Conclusion: During the 10 year period of review, only 62 articles were published analysing routinely collected HIV data
in Zambia. Serious consideration needs to be made to maximise the utility of routinely collected data, and to benefit
from the funds and efforts to collect these data. This could be achieved with government support of operational
research and publication of findings based on routinely collected Zambian HIV data.
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Background
Worldwide, many countries routinely collect data on
HIV care and services, which is then used to provide
national and international indicators about the HIV
epidemic. These indicators provide information and
insight to aid policymakers and planners when mak-
ing important decisions about HIV services, to re-
quest for further research, and in advocacy for new
initiatives and funding [1, 2].
Sub-Saharan Africa is home to approximately 71% of
the people living with HIV [3]. Zambia is a high HIV
burden country within sub-Saharan Africa, having a na-
tional HIV prevalence of 11.6% and almost 980,000
people living with HIV in 2016 [4–6]. The HIV epidemic
in Zambia is generalised and is mainly attributed to un-
protected heterosexual activity [7]. This creates a need
to monitor the HIV epidemic by focusing on indicators
of effective prevention and on the quality of the HIV ser-
vices in Zambia [8]. Six key service areas are prioritised
in the country for prevention and treatment of HIV.
These are (1) voluntary medical male circumcision
(VMMC); (2) condom programming; (3) behavioural
change; (4) HIV testing and counselling (HTC); (5)
prevention of mother-to-child transmission (PMTCT);
and (6) treatment and retention in care [7]. At national
level, these programmes are monitored using routinely
collected data and periodic country representative surveys.
Routinely collected data can also be used to under-
stand the effectiveness of services and to improve
decision-making in the healthcare system. The benefits
in using routinely collected data include wider coverage
of recorded items from across the whole country and
the longitudinal nature of the data allowing estimation
of trends and changes in the use of services [9]. The use
of these data in this way is cost effective, as it is already
collected and readily available for analysis. Therefore, re-
search can be conducted in a timely and cost-efficient
manner [10]. It can be the basis of sampling for clinical
trials, cohort studies and case-control studies, as
matched case-control analyses can be performed repeat-
edly over long time periods [11]. Routinely collected data
are usually clinic based, but results from analysis of such
data can be generalisable to the whole population if the
services are widely used and serve all sections of society
[10]. One of the main data collection systems for the
routine collection of data from the HIV programme is
SmartCare, which is one of the largest electronic patient
monitoring systems (PMS) in Africa and is used in South
Africa and Ethiopia [12]. In Zambia, the SmartCare
database is used as a PMS for HIV services, and the data
are used to monitor and plan improvements in the
country’s HIV programme. SmartCare has been used as
a pilot since 2004, and was officially rolled out in 2006
[13], with 528 clinics using SmartCare in 2012, and
implemented in more than 700 clinics that provide anti-
retroviral therapy services by 2013 [14, 15]. SmartCare
data, in facilities where it is available, is used to provide
aggregate reports for DHIS2, and other health manage-
ment information systems at the district level. In some
health facilities, the SmartCare data can inform the drug
ordering and the laboratory information systems, but
this is not possible in most health facilities in Zambia.
Research has revealed that countries like Zambia, with
one of the highest HIV/AIDS prevalence rates in Africa,
are not the largest contributors to research on HIV/
AIDS. This was evident in a review of three journals fo-
cusing on HIV/AIDS [16], which showed that the United
States of America and Western Europe accounted for
85% of all published articles between 1986 and 2003. In
sub-Saharan Africa, 50% of all publications on Africa
indexed in PubMed between 1981 and 2009 were from
South Africa, Uganda and Kenya. Zambia was ranked
seventh, with 922 publications within that period, trans-
lating to approximately 32 publications per year [17].
This paper is a review of published studies using rou-
tinely collected HIV data from Zambia from 2004 to
2015, within the six areas of focus (VMMC, condom
programming, behavioural change, HTC, PMTCT, and
treatment and retention in care). We sought to examine
the extent to which routinely collected HIV data has
been analysed quantitatively for publication and identify
gaps that exist across the six prioritised areas. It is hoped
that findings from this review will potentially inform
guidelines and strategies as well as stimulate policy
dialogue in the use of routinely collected data.
Methods
Literature search strategy
We conducted a literature review of studies that
reported results from routinely collected HIV data in
Zambia. We utilised a detailed search protocol and
standard systematic review procedures (Additional file 1)
for papers which utilised routinely collected HIV data
from primary to tertiary healthcare settings, using
SmartCare or other electronic or paper-based PMS data
in Zambia. We included studies published between 2004
(when SmartCare started) and November 2015. The
search was conducted between July and November 2015.
We selected only original articles from peer-reviewed
journals on HIV studies conducted in Zambia utilising
routinely collected data and quantitative methods of data
analysis. All reported studies relevant to our search topic
were reviewed, regardless of sample size. Articles were
excluded if they were not written in English or where
the specific results for Zambia were not reported from
regional or multi-country studies. Clinical trials and
intervention studies that did not take place under
routine care conditions were also excluded, although
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community trials that referred patients to the routine
clinics were included.
We searched the PubMed, Google Scholar, Directory
of Open Access Journals, and African Journals Online
databases for articles on HIV in Zambia that utilised
routinely collected data (Table 1). We used a combin-
ation of search words that included “HIV”, “SmartCare”
and “routinely collected data”, among others (Table 1).
One of the authors (TM) searched for articles and ex-
tracted the data from included studies, while another au-
thor (SG) reviewed the extracted data for discrepancies.
All discrepancies were discussed and resolved. A stand-
ard data extraction form was used to review and extract
data such as sample size, study design, number of study
sites, dates of data collection, year of publication and
main outcomes.
Data analysis
The selected papers could only be categorised by the six
programme areas as the range of topics covered pre-
vented aggregated statistical analysis of findings. All eli-
gible articles were further grouped by the populations
used in the papers, namely adult (males and females
above 15 years of age), women and children (under the
age of 15 years) to assess how effectively the priority
areas cover the different age categories. The eligible arti-
cles were also analysed based on institutions that collab-
orated to publish the articles.
Results
A total of 1846 titles were reviewed and 1048 were
excluded because they were not published in journals (n
= 482), were published before 2004 (n = 335), or the
topics were not relevant (n = 231). A total of 791 ab-
stracts were then reviewed. Of these, some were ex-
cluded because they were clinical trials (n = 39),
qualitative studies (n = 110), or did not use routinely
collected data (n = 470), or were multi-country studies
that did not include specific data on Zambia (n = 103)
(Fig. 1). From these, 69 full length articles were selected,
of which seven were found to be multi-country studies
that did not use routinely collected data, and the remaining
62 were considered for categorisation. The articles were
then classified into the six HIV service areas.
Overall, 15 articles addressed PMTCT, four focussed
on HTC, four covered social and behavioural change
(Table 2), and 39 covered treatment and retention in
care. Our search did not reveal any articles that used
routinely collected HIV data in Zambia reporting out-
comes in the areas of condom programming or VMMC
utilising quantitative methods.
The majority of the papers were mostly large samples,
with thousands of subjects, covering many different
health facilities. The articles on HIV treatment and
retention in care covered topics such as enrolment and
retention into antiretroviral therapy, effectiveness of
different drug regimens, coinfections with laboratory
confirmed pathogens, comorbidities using clinical signs
and symptoms, and food supplementation (Table 3). The
15 PMTCT articles found addressed elimination of
paediatric HIV infections, transmission of HIV to the
babies, and improvement of survival in infected mothers
and their exposed children.
We found four articles on HTC covering couple coun-
selling and provider-initiated testing and counselling. Ar-
ticles on social and behaviour change looked at creating
demand for adherence, prevention interventions, im-
proved biomarkers and treatment uptake. Treatment
and care had the largest number of articles with 39 arti-
cles covering the topic (Table 3). Of the 62 articles, 33
full length papers utilised adult only routinely collected
data and addressed retention in care, access to HIV
treatment, mortality and clinical outcomes. A total of 16
full-length articles used data from only women, covering
contraception, PMTCT and antenatal HIV prevalence
rates. The articles using data on women only were pub-
lished between 2010 and 2011, and had sample sizes
ranging from 1435 to 138,884. There were 13 peer-
reviewed articles that addressed paediatric HIV care and
treatment. These were published between 2007 and
2013, with sample sizes ranging from 1120 to 4975. Our
search did not reveal any articles utilising routinely col-
lected HIV data specifically on adolescents aged 10–24
years old.
The 62 papers analysed were published in collabor-
ation with partner institutions (Fig. 2). The Centre for
Infectious Disease Research in Zambia and the Univer-
sity of Alabama had the highest contribution, with col-
laboration on 42 and 29 papers, respectively. The staff
from national and district levels of the Ministry of
Health participated in 40 of the published articles,
while the lower collaboration was from institutions
based in the United Kingdom, with collaboration on
Table 1 Search strategy
Database Search terms
Google Scholar (July 3, 2015) HIV + SmartCare +
Zambia HIV + routine + data HIV/AIDS
+ “routinely collected data” + Zambia
Condom + HIV + Zambia
PubMed (July 15, 2015) HIV/AIDS + “routinely collected data”
+ Zambia + routine data
Condom + HIV
African Journals Online
(November 6, 2015)
HIV + routine + data + Zambia +
condom + "routinely collected data" +
SmartCare
Directory of Open Access
Journals (November 11, 2015)
HIV + Zambia + condom + "routinely
collected data" + SmartCare
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only 8 articles, four from LSHTM and four from
other universities.
Discussion
The review of published articles showed that consider-
able strides are being made in utilisation of routinely
collected HIV data in Zambia. A total of 62 articles were
found and considered in this review. Treatment and
retention in care and PMTCT had the highest contribu-
tion, with counselling and social and behavioural change
having four articles each. However, we could not find
published papers that utilised quantitative data analysis
methods in our search on VMMC and condom pro-
gramming despite the importance of these programmes
and the inclusion of data from these programmes in
SmartCare. The broad focus of the literature search on
HIV in Zambia should have identified many papers on
condom programming or VMMC, but the only papers
found were qualitative studies on these topics. It was
also observable during the search process that quantita-
tively analysed studies on HIV in adolescents in the
country were limited and information for this age group
has to be extracted from paediatric and adult studies.
This study was a collection of articles covering a di-
verse range of topics, which meant that no meta-analysis
of the studies was possible. One of the goals of this
paper was to highlight the range and diversity of the
topics available for analysis using routinely collected
data, and to explore the gaps in the published literature
so far. The main topics were grouped into treatment and
retention in care, PMTCT, HTC, condom programming
and VMMC. Our search on VMMC and condom
programming revealed no quantitatively analysed papers
and few qualitatively analysed papers.
We did not include a large number of qualitatively
analysed, clinical trial and survey-based articles, which
have made important contributions to policy change in
HIV care and treatment in Zambia. Further, risk of bias
in individual study papers selected was not prioritised
during the selection process since the rationale of the re-
view was to assess the extent of utilisation of routinely
collected data in the country. Only peer-reviewed
articles where included because the assumption was that
the peer-review process implies some form of quality
control for biases in selected papers. In addition, only
one of the authors reviewed the titles and abstracts,
Fig. 1 Flow diagram of review of routinely collected HIV data in Zambia
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which could be a source of bias. However, as far as we
are aware, this is the first study to provide such a
baseline of studies for future referral.
The total number of published articles found in our
literature search on the six HIV programmatic areas
using routinely collected data meeting our criteria was
quite low (an average of six articles per year) consider-
ing that these have been published in the past 10 years.
This finding is lower than the 32 articles per year re-
ported by Uthman [17], but in line with findings by the
Ministry of Health [18], where the use and analysis of
routinely collected data were found to be inadequate in
Zambia, with analysed data displayed in graphs and
information from the districts rarely used for decision-
making at district levels. The reasons for these low
numbers could be the limited data analysis skills, un-
availability of data analysis software, disapproval or lack
of support from supervisors, and lack of time and op-
portunity [9–11, 18–20]. It could be further argued that
the limited use of routinely collected data was due to
lack of knowledge on the benefits of analyzing such
data at facility and district levels and poor data man-
agement, which could be alleviated by deliberate policy
from government to support existing staff capacity
building, operational research and publication of find-
ings [18, 21].
Table 2 Studies utilising routinely collected data in HIV testing and counselling, prevention of mother-to-child transmission (PMTCT)
and social behavioural change programmes in Zambia
First author, year of publication Data collection period Sample size Sampled population Outcomes assessed
HIV testing and counselling
Topp et al. [31] 2008–2011 2239 Adults only CD4 count, haemoglobin level, BMI, education level,
partner’s HIV status
Topp et al. [32] 2008–2010 44,420 Adults only HIV testing, enrolment into care
Czaicki et al. [33] 2011–2012 10,806 Adult couples Cohabitation length, prior HIV testing, current
antiretroviral use
Kankasa et al. [34] 2006–2007 15,670 Children HIV testing, testing coverage, HIV counselling,
PMTCT
Killam et al. [35] 2007–2008 13,917 Women initiating ART Women eligible for ART, women initiating ART
Stringer et al. [36] 2001 17,263 Women only Women tested, mothers and babies receiving NVP
Stringer et al. [37] 2003 8787 Mother baby pairs Gravidity, offered testing, tested, infant given NVP
Chibwesha et al. [38] 2007–2010 1813 Mother baby pairs CD4 count, date of highly active ART initiation, infant
HIV status
Liu et al. [39] 2007– 2009 13,888 Women initiating ART CD4 count, haemoglobin level, syphilis, tuberculosis,
HIV status
Chintu et al. [40] 2004–2006 6740 Women on ART Mortality, NVP exposure, CD4 count, haemoglobin
level
Mandala et al. [41] 2007–2008 14,815 Women on ART CD4 count, initiated on ART
Torpey et al. [20] 2005–2008 9723 Women on ART HIV testing, enrolled to care, received ART
Chibwesha et al. [42] 2009–2010 18,407 Women initiating ART CD4 count, haemoglobin level, use of contraceptives
Stringer et al. [43] 2002–2006 243,302 Women and baby pairs HIV status, number testing positive, attended
antenatal care
Mulindwa [44] Not stated 146 Women initiating ART NVP toxicity, hepatic toxicity, WHO grading of toxicity
Ngoma et al. [45] 2008–2009 279 Women only HIV-free at 12 months, mortality rates, HIV
transmission
Torpey et al. [46] 2007–2010 28,320 Children only HIV testing, type of PMTCT regimen
Torpey et al. [47] 2007–2009 8237 Children HIV testing, type of PMTCT regimen
Albrecht et al. [48] 2001–2003 760 Women only PMTCT drug adherence, partner disclosure
Social and behavioural change
Kankasa et al. [34] 2004–2007 27,115 Adults on ART Adherence, mortality, loss to follow-up, CD4 count
Goldman et al. [49] 2006–2007 913 Adults on ART Adherence, viral load
Carlucci et al. [50] 2006 542 Adults on ART Drug adherence
Birbeck et al. [51] 2005–2006 255 Adults on ART Drug adherence
ART antiretroviral therapy, BMI body mass index, NVP nevirapine
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Table 3 Studies utilising routinely collected data on HIV treatment and retention in care in Zambia
First author Data collection period Sample size Sampled population Outcomes assessed
Cantrell et al. [52] 2004–2005 636 Adults on ART Adherence to medication, CD4, weight gain
Koethe et al. [53] 2004–2008 27,915 Adults initiating ART Weight gain, death, treatment failure, BMI
Tirivayi et al. [54] 2009 291 Adults on ART Adherence to medication, CD4, BMI
Koethe et al. [55] 2004–2009 56,612 Adults on ART CD4, mortality, BMI
Stringer et al. [56] 2004–2007 14,736 Adults on ART Single dose substitution, CD4 count, haemoglobin
level, BMI, mortality
Chi et al. [57] 2007–2010 18,866 Adults initiating ART CD4, clinical disease staging, BMI, serum creatinine
adherence, mortality
Chi et al. [58] 2007–2009 10,485 Adults on ART Drug substitution, mortality, loss to follow-up,
withdrawal and death
Chi et al. [59] 2004–2008 24,366 Adults on ART CD4 counts, age clinical staging, haemoglobin,
tuberculosis co-infection, adherence
Chi et al. [60] 2007 33,704 Adults on ART Cut-off points defining loss to follow-up, sensitivity,
specificity, misclassification rate
Giganti et al. [61] 2004–2010 40,410 Adults on ART Haemoglobin level, CD4, ART regimen
Vinikoor et al. [62] 2015 20,308 Adults on ART HBsAg, CD4, BMI, WHO staging
Mulenga et al. [63] 2004–2007 25,779 Adults on ART Mortality, creatinine clearance
Stringer et al. [64] 2004–2005 21,755 Adults initiating ART Clinical staging, CD4, mortality, BMI, haemoglobin
level, adherence
Seu et al. [65] 2009–2012 68 Adults failing treatment CD4 count, adherence, HIV drug resistance
mutations
Krebs et al. [66] 2005 1343 Adults lost to follow-up CD4 count, BMI, mortality, home visit categories
(traced, untraceable, died)
Vinikoor et al. [67] 2004–2010 53,015 Adults missing pharmacy
refills
CD4 count, clinical staging, pharmacy refills,
adherence, ART regimen
Vinikoor et al. [68] 2004–2011 92,130 Adults on ART Adherence, CD4 count, mortality, long-term follow-
up
Harris et al. [69] 2005–2007 20,153 Tuberculosis/HIV co-infected
adults
Enrolment on ART, CD4 count, WHO staging
Mweemba et al. [70] 2011–2013 91,130 Adults initiating ART Hepatitis B co-infection, WHO staging, CD4 count
Deo et al. [71] 2007 13 Laboratories CD4 count, haemoglobin, liver function test
Chi et al. [72] 2004–2006 6740 Women exposed to
nevirapine
WHO stage, CD4 cell count, status, BMI
Bolton-Moore et al. [73] 2004–2007 4975 Children on ART CD4 percentage, weight-for-age Z scores, clinical
staging, haemoglobin level, mortality
Mubiana‐Mbewe et al. [74] 2004–2006 1705 Children enrolled into care CD4 percentage, clinical staging, haemoglobin level
Scott et al. [75] 2006–2011 1334 Children on ART CD4 percentage, fixed and variable unit costs
Kiage et al. [76] 2009–2011 822 Mother-infant pairs WHO staging, CD4/CD8 percentage, HIV, haemoglobin
panel, maternal-CD4 count
Sutcliffe et al. [77] 2004–2008 1278 Children on ART Enrolment in ART, loss to follow-up, mortality, clinical
staging, CD4 percentage
Iyer et al. [78] 2006–2011 1102 Children initiating ART Age, CD4 percentage, ART initiation, full blood count,
blood chemistry
Sutcliffe et al. [79] 2004–2008 863 Children on ART Mortality, CD4, HIV, haemoglobin level
Sutcliffe [80] 2000–2002 492 Children on ART CD4 count, haemoglobin level, mortality
Van Dijk et al. [81] 2007–2012 77 Children on ART Weight-for-age Z scores, CD4 percentage
Van Dijk et al. [82] 2007–2010 198 Children on ART Treatment outcomes, viral load, CD4 percentage,
retention in care, mortality
Sutcliffe et al. [83] 2007–2009 193 Children initiating ART Weight-for-age and height-for-age Z scores
Nkamba [84] Not stated 59 Children on ART T cell subsets CD4 and CD8 memory
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Treatment and retention in care had the largest num-
ber of studies. This is in line with global trends in HIV
prevention strategies where treatment and retention in
care have been identified as the most effective HIV
prevention tool among the biomedical prevention tools
analysed to date [22, 23]; more research is encouraged in
these areas. However, considering the period under
review, the number of studies found on retention and
care were rather low. Similar trends of low levels of pub-
lication in this area have been attributed to long follow-
up periods required to monitor retention in care as well
as to inconsistent information systems that make it difficult
to track patients that seek care from multiple facilities [24].
There was also a limited number of studies that looked
at children born with HIV infection identified in our
search. This is in line with findings from a systematic re-
view of care and retention in HIV-infected children in
low- and middle-income countries, where limited data
were also found in Asia, Eastern Europe and Latin
America [25], attributed to emphasis on studies on adult
data. It was also apparent that no quantitative peer-
reviewed studies on treatment and retention among ado-
lescents already in HIV care in Zambia were found in
our search. Data on this age group has to be extracted
from paediatric and adult studies. Similar findings have
been reported in studies conducted in southern Africa in
2009 [26] and 2010 [27], where few data were reported
on perinatally infected adolescents with most of the
available data on adherence and outcomes emerging
from the developed world. It is further argued that data
for adolescents in southern Africa are disaggregated into
0–14, 15–19 and 15–24 year age groups, which makes it
difficult to ascertain adolescent-specific data since, in
most cases, the data includes very young children or
adults [28].
The search on condom programming revealed mostly
intervention studies in settings where prospective users
could access them. Reasons for this could be the mode
of distribution, which is restricted to public health facil-
ities and to private health facilities only on request [29].
Similarly, Kane et al. [30] argued that use of aggregate
data on condom sales does not provide information on
utilisation of condoms after they are obtained, resulting
in the need for in-depth analysis on factors associated
with condom use. The same could be concluded on use-
fulness of aggregate condom distribution data. Moreover,
condom distribution data are difficult to document in
routinely collected data and thus there is heavy reliance
Table 3 Studies utilising routinely collected data on HIV treatment and retention in care in Zambia (Continued)
Van Dijk et al. [85] 2007–2008 192 Children on ART Years of receiving ART, distance from clinic,
CD4 percentage, weight-for-age Z score
Sinkala et al. [86] 2005–2006 5609 Adults only Colonoscopy, laparoscopy, culture results
Sheyo [87] 2009–2010 452 Adults and children HIV status, burn history, burn outcome and
management
Brugha et al. [88] 2004–2007 39 Health facilities VCT, ART, PMTCT, childhood immunisation service
and coverage trends
Kancheya et al. [89] 2003–2006 203 Adults HIV status, VCT
Kaile et al. [90] 2004 18 Adults on ART Blood pressure serum potassium, creatinine and
sodium, Karnofsky score, WHO staging
ART antiretroviral therapy, BMI body mass index, PMTCT prevention of mother-to-child transmission, VCT voluntary counselling and testing
Fig. 2 Graph showing number of articles published by each collaborating institution
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on survey data [7]. There is an urgent need to under-
stand the demographics of condom distribution in the
country. Similar trends were revealed in the VMMC
programme, which also yielded low numbers of peer-
reviewed articles that utilised routinely collected quantitative
data, despite the country not meeting its circumcision
targets [7].
Conclusion
There are positive advances being made in the HIV
programme in the use of routinely collected data in
Zambia. This progress must be nurtured and enhanced
if Zambia is to reach elimination stages in HIV control.
However, more efforts must be put into research and
publishing results in critical areas, such as paediatric and
adolescent care, VMMC and condom distribution, in
order to build the skills and knowledge-base to deliver
HIV services. Research on adolescent and childhood
HIV morbidity and mortality outcomes as well as social
behavioural change needs is important because HIV-
infected adolescents and children are the key population
in reducing HIV spread in their generation.
To improve the use of routinely collected data for use in
publications the government could deliberately put in
place policies to prioritise training of civil servants work-
ing in various programmes in operational research and
consequently fund publishing of findings. These published
articles would aid in international resource mobilisation
for most programmes in the country as programme level
data can be easily accessed in peer-reviewed articles.
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